Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Updated:
May 15, 2024
Fusion Antibodies PLC
Net Income
|
Fusion Antibodies PLC
Net Income Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Net Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Net Income
-£2.8m
|
CAGR 3-Years
-60%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Net Income
-£149.8m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Net Income
-£365k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Net Income
£564k
|
CAGR 3-Years
4%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Net Income
£15m
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Net Income
£11.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Net Income?
Net Income
-2.8m
GBP
-2.8m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Net Income amounts to -2.8m GBP.
What is Fusion Antibodies PLC's Net Income growth rate?
Net Income CAGR 5Y
-17%
-17%
Over the last year, the Net Income growth was -64%. The average annual Net Income growth rates for Fusion Antibodies PLC have been -60% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
